New Insight into Therapies Targeting Angiogenesis in Hepatocellular Carcinoma

Cancers
Monica MossentaMichele Dal Bo

Abstract

Hepatocellular carcinoma (HCC) is a malignancy characterized by neoangiogenesis that is determined by an augmented production of proangiogenesis factors by tumor and adjacent cells. This unbalanced angiogenesis process is a key feature of HCC carcinogenesis and progression. Proangiogenic factors also have a relevant role in the generation and maintenance of an immunosuppressive tumor microenvironment. Several therapeutic options for HCC treatment are based on the inhibition of angiogenesis, both in the early/intermediate stages of the disease and in the late stages of the disease. Conventional treatment options employing antiangiogenic approaches provide for the starving of tumors of their blood supply to avoid the refueling of oxygen and nutrients. An emerging alternative point of view is the normalization of vasculature leading to enhance tumor perfusion and oxygenation, potentially capable, when proposed in combination with other treatments, to improve delivery and efficacy of other therapies, including immunotherapy with checkpoint inhibitors. The introduction of novel biomarkers can be useful for the definition of the most appropriate dose and scheduling for these combination treatment approaches. The present review provid...Continue Reading

References

Apr 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·T FotsisL Schweigerer
Jul 22, 1997·Proceedings of the National Academy of Sciences of the United States of America·P H MaxwellP J Ratcliffe
Aug 2, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·E BråkenhielmY Cao
Dec 24, 2003·The Cancer Journal·Diane D Davey
Aug 7, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Zongxian CaoBing-Hua Jiang
Apr 20, 2005·The Journal of Surgical Research·S J StaffordE A Woltering
Dec 8, 2005·Biochemical Pharmacology·Gianluigi GiannelliAngelo Paradiso
Mar 2, 2006·Journal of the National Cancer Institute·Francesca CarlomagnoMassimo Santoro
Apr 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew X ZhuKeith Stuart
May 2, 2006·Molecular Cancer Therapeutics·Daniel H AlbertSteven K Davidsen
Sep 30, 2006·Cancer Chemotherapy and Pharmacology·Chong-Zhi WangChun-Su Yuan
Nov 24, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Betty LiKarin Jooss
Dec 14, 2006·Proceedings of the National Academy of Sciences of the United States of America·Klaus PodarKenneth C Anderson
Jan 24, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Caroline BouzinOlivier Feron
Feb 10, 2007·Current Oncology Reports·Guru Sonpavde, Thomas E Hutson
Aug 11, 2007·Nature Reviews. Drug Discovery·Sandrine FaivreEric Raymond
May 20, 2008·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Zhen Fan Yang, Ronnie T P Poon
Jul 25, 2008·The New England Journal of Medicine·Josep M LlovetUNKNOWN SHARP Investigators Study Group
Feb 7, 2009·Nature Reviews. Immunology·Dmitry I Gabrilovich, Srinivas Nagaraj
Jun 24, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roy S HerbstLee S Rosen
Dec 17, 2009·Angiogenesis·Kristy J Gotink, Henk M W Verheul

❮ Previous
Next ❯

Citations

Feb 15, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Heba T Abdel-MohsenMathias O Senge
Jul 12, 2020·Bulletin of Experimental Biology and Medicine·Yu S TaskaevaN P Bgatova
Mar 19, 2020·Cell Communication and Signaling : CCS·Ji-Yan XieJun Min
Nov 21, 2020·Expert Review of Gastroenterology & Hepatology·Alessandro RizzoGiovanni Brandi
Feb 16, 2021·Frontiers in Oncology·Clelia DonisiMario Scartozzi
Nov 3, 2020·Expert Review of Gastroenterology & Hepatology·Hui Li
Jan 20, 2020·Journal of Hepatology·Sandrine FaivreRichard S Finn
Apr 4, 2021·International Journal of Molecular Sciences·Kuo-Shyang JengChiung-Fang Chang

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
xenograft

Clinical Trials Mentioned

NCT00105443
NCT00492752
NCT03439891
NCT03211416
NCT01774344
NCT01761266

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Related Papers

Expert Opinion on Drug Delivery
Krassimira Yoncheva, Georgi Momekov
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
R A Pazo-CidP Martín-Duque
World Journal of Hepatology
Andreas PircherJoachim Drevs
© 2021 Meta ULC. All rights reserved